-
Document de presse | 2025.05.29
The plague bacillus became less virulent, prolonging the duration of two major pandemics
Scientists at the Institut Pasteur and McMaster University have discovered that the evolution of a gene in the bacterium that causes bubonic plague, Yersinia pestis, may have prolonged the duration of two major pandemics. They have demonstrated that modifying the copy number of a specific virulence gene increases the length of infection in affected individuals. It is thought that this genetic...
-
Document de presse | 2025.05.29
Revelations on the History of Leprosy in the Americas
Leprosy existed in America long before the arrival of Europeans: a new study reveals the history of a neglected pathogen.Long considered a disease brought to the Americas by European colonizers, leprosy may actually have a much older history on the American continent. Scientists from the Institut Pasteur, the CNRS, and the University of Colorado (USA), in collaboration with various institutions...
-
Vidéo | 2025.06.10
Avian flu: should we be worried?
Avian flu is all over the news... but what is the real risk to humans?Marie-Anne Welti, head of the Molecular Mechanisms of Pneumovirus Multiplication unit at the Institut Pasteur, takes stock of the current situation.The H5N1 virus, responsible for avian flu, mainly affects birds, but has also been detected in farmed mammals, such as dairy cows in the USA since 2024.In France, cases were...
-
Article | 2021.10.04
The Institut Pasteur “Apprentis Chercheurs” program
The Institut Pasteur hosts the “Apprentis Chercheurs” program for High School students to encourage the participation in STEM (Science Technology Engineering Maths). The project is in partnership with the “Arbre des Connaissances” association which endeavors to introduce young students to the fields of experimentation and debate in science.
-
News | 2025.05.22
Steroid hormone levels vary with age, sex ... and lifestyle
A large-scale ten-year study conducted by the Institut Pasteur on a thousand individuals has shed new light on steroid hormones. Levels of these molecules, which play a crucial role in our health, vary over time – sometimes to a significant extent – influenced by sex and lifestyle factors. The results of this research were recently published in Science Advances.
-
News | 2025.06.11
The Institut Pasteur, Fiocruz and Sanofi establish strategic alliance for vaccine development
During the official visit of Brazilian President Luiz Inácio Lula da Silva to France, the Oswaldo Cruz Foundation (Fiocruz), the Institut Pasteur and Sanofi formed a strategic alliance aimed at fostering innovation and advance vaccine technologies. A Memorandum of Understanding (MoU) was signed on Thursday, June 5, laying the groundwork for scientific and technical cooperation in the field of...
-
Article | 2017.01.03
Pasteur-Paris University International doctoral program (PPU)
The Institut Pasteur organizes a doctoral program in collaboration with Université Paris Cité, Sorbonne Université, and Université Paris Saclay, for students holding a master degree or the equivalent in science, medicine and related fields.
-
Article | 2017.01.05
E-learning / Mooc
Institut Pasteur creates online courses (MOOCs) on various scientific topics, ranging from major biological questions to public health issues.
-
Vidéo | 2025.06.16
Lung cancer: A major breakthrough thanks to AI!
A better understanding of lung cancer thanks to artificial intelligence: an unprecedented breakthrough supported by Institut PasteurFor the first time in the world, researchers have succeeded in mapping the organization of immune cells in the tumor environment of aggressive lung cancer, using an innovative approach based on AI and biological imaging.This work is led by Jean-Christophe Olivo-Marin...
-
News | 2025.05.28
Launch of a therapeutic trial of a new treatment for hidradenitis suppurativa
Hidradenitis suppurativa is a skin condition that causes painful abscesses in skin folds. There are three stages of the disease. A new clinical trial, ABCESS2, has recently been launched to treat stage II hidradenitis suppurativa. The trial is being led by the Institut Pasteur.
